Gemcitabine-Oxaliplatin Regimen

DRUG2 trials

Sponsors

University Hospital, Montpellier, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Conditions

Cholangiocarcinoma Non-resectableIntrahepatic CholangiocarcinomaNon-metastatic

Phase 2

Hepatic Arterial Infusion of Gemcitabine-oxaliplatin for Second-line Therapy in Non-metastatic Unresectable Intra-hepatic Cholangiocarcinoma

RecruitingNCT03364530

University Hospital, MontpellierCholangiocarcinoma Non-resectable, Non-metastatic

Start: 2018-06-11End: 2026-10-21Target: 40Updated: 2026-01-05

Unknown Phase

GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC

RecruitingNCT06505486

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityIntrahepatic Cholangiocarcinoma

Start: 2024-07-10End: 2025-07-10Target: 21Updated: 2024-07-17